(S)-(+)-2-氨基-3-(2-氨基乙氧基)丙酸赖氨酸
(S)-(+)-2-氨基-3-(2-氨基乙氧基)丙酸赖氨酸
(S)-(+)-2-氨基-3-(2-氨基乙氧基)丙酸赖氨酸 性质
| 熔点 | 212-216 °C(lit.) |
|---|---|
| 比旋光度 | +4.0~+8.0°(c=10,dilHCl)(D/20) |
| 储存条件 | Store at -20°C |
| 溶解度 | 溶于二甲基亚砜 |
| 形态 | 固体 |
| 颜色 | 白色至米白色 |
(S)-(+)-2-氨基-3-(2-氨基乙氧基)丙酸赖氨酸 用途与合成方法
Alpha-fetoprotein (AFP) is expressed in BEL-7404 human hepatoma cells and L-4-Oxalysine suppresses AFP mRNA expression in the cells. L-4-oxalysine functionally antagonizes the a-fetoprotein-induced suppression of the mitogen- and one-way mixed lymphocyte culture-induced proliferation of spleen lymphocytes and interleukin-6 production by these cells in mice bearing the hepatoma-22 tumor.
Tbe ultrastructural efects of different doses of L-4-Oxalysine on hepatocytes in mice are most serious at day 1 after stopping treatment. Mice are given ig L-4-oxalysine (I-677) 10, 50, and 100 mg/kg for 7 d. On day 8 the hepatocytes show accumulation of lipid droplets followed by loss of matrices in cytoplasm. The total area of lipid droplets is far less than 25% of mean section of hepatocytes. The injury of mitochondria and RER is only found in the groups of medium and high dose. L-4-oxalysine inhibits the proliferation of some mouse implanted tumors and pulmonary metastasis of mouse Lewis lung carcinoma.
(S)-(+)-2-氨基-3-(2-氨基乙氧基)丙酸赖氨酸 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-06-05 | HY-U00097 | (S)-(+)-2-氨基-3-(2-氨基乙氧基)丙酸赖氨酸 | 118021-35-5 | 5 mg | 2000 |
| 2026-06-05 | HY-U00097 | (S)-(+)-2-氨基-3-(2-氨基乙氧基)丙酸赖氨酸 | 118021-35-5 | 10 mM * 1 mL in Water | 2200 |